Today, Acorai, a start-up medical device manufacturer from Sweden, has announced the initiation of a global clinical trial with the enrollment of its first patient in London, UK. Acorai was designated as a breakthrough device by the US FDA in August 2023 and they aim to submit their heart monitor for regulatory approval to the FDA and CE-marking in 2024. Continue reading
Alas, poor Twitter; we knew it well. Or, at least, we thought we did. Despite never occupying more than 10% of social media’s online presence, western audiences are very aware of the platform. That’s not least because of the way that the mass media echoes and amplifies the controversies and outrage born on Twitter.
Having dipped somewhat during the pandemic, sexually transmitted infections (STIs) are on the rise again around the world. In England and Ireland in 2022, rates of chlamydia, gonorrhoea and syphilis exceeded levels recorded before COVID. The number of gonorrhoea diagnoses recorded in England was in fact the highest since annual records began.